I-Hsin Kuo, MS, Takeshi Yoshida, PhD, Anna De Benedetto, MD, Lisa A

Slides:



Advertisements
Similar presentations
Advances in rhinitis and rhinosinusitis in 2015
Advertisements

Jason E. Hawkes, MD, Tom C. Chan, MD, PhD, James G. Krueger, MD, PhD 
Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses  Chris J. Corrigan, MD, PhD, Wei.
Doina M. Racila, MD, Joel N. Kline, MD, MSc 
Innate microbial sensors and their relevance to allergy
Natalija Novak, MD  Journal of Allergy and Clinical Immunology 
Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies  Ludmila Perelygina, PhD, Stanley.
TNF-α–mediated bronchial barrier disruption and regulation by src-family kinase activation  Michelle A. Hardyman, PhD, Emily Wilkinson, BSc, Emma Martin,
Donald Y.M. Leung, MD, PhD, Emma Guttman-Yassky, MD, PhD 
Reduced IFN-γ receptor expression and attenuated IFN-γ response by dendritic cells in patients with atopic dermatitis  Eva Gros, MSc, Susanne Petzold,
Atopic dermatitis: Age and race do matter!
Calcitonin gene-related peptide– and vascular endothelial growth factor–positive inflammatory cells in late-phase allergic skin reactions in atopic subjects 
Activation of protease-activated receptor 2 leads to impairment of keratinocyte tight junction integrity  Peter Nadeau, BS, Mason Henehan, BS, Anna De.
Atopic dermatitis results in intrinsic barrier and immune abnormalities: Implications for contact dermatitis  Julia K. Gittler, BA, James G. Krueger,
Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human β-defensin-3  Kevin O. Kisich, PhD, Charles.
Jason E. Hawkes, MD, Tom C. Chan, MD, PhD, James G. Krueger, MD, PhD 
Therapeutic pipeline for atopic dermatitis: End of the drought?
Is 9 more than 2 also in allergic airway inflammation?
Interplay between the skin barrier and immune cells in patients with atopic dermatitis unraveled by means of mathematical modeling  David Bending, PhD,
Allergic skin diseases
An Infant with Atopic Dermatitis and Itching After Ingestion of Milk
Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses  Chris J. Corrigan, MD, PhD, Wei.
Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis  Kazue Yoshida,
Yuichi Teraki, MD, Aika Sakurai, MD, Seiichi Izaki, MD 
Advances in rhinitis and rhinosinusitis in 2015
The National Biome Initiative: An allergy perspective
Advances in atopic dermatitis and urticarial in 2016
A network-based analysis of the late-phase reaction of the skin
Epithelium: At the interface of innate and adaptive immune responses
Kathleen C. Barnes, PhD  Journal of Allergy and Clinical Immunology 
Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis  Shunya Mashiko, BPharm, Salim Bouguermouh, MD, PhD, Manuel.
Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis  Anna De Benedetto, MD, Mark K. Slifka, PhD,
Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march  Tali.
Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march  Gyohei Egawa, MD, PhD, Kenji Kabashima, MD,
Expression of the cysteinyl leukotriene receptors cysLT1 and cysLT2 in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis  Chris Corrigan,
A survivor: The eosinophil as a regulator in asthma
Receptor-interacting protein kinase 3 controls keratinocyte activation in a necroptosis- independent manner and promotes psoriatic dermatitis in mice 
The Editors' Choice Journal of Allergy and Clinical Immunology
Skin Barrier Disruption: A Requirement for Allergen Sensitization?
Atopic dermatitis: A practice parameter update 2012
Biosimilars and drug development in allergic and immunologic diseases
Breakdown in epithelial barrier function in patients with asthma: Identification of novel therapeutic approaches  Emily J. Swindle, PhD, Jane E. Collins,
Lisa G. Wood, PhD, Manohar L. Garg, PhD, Peter G. Gibson, MBBS 
CC chemokine receptors CCR1 and CCR4 are expressed on airway mast cells in allergic asthma  Kawa Amin, PhD, Christer Janson, MD, PhD, Ilkka Harvima, MD,
What is an “eosinophilic phenotype” of asthma?
The L412F variant of Toll-like receptor 3 (TLR3) is associated with cutaneous candidiasis, increased susceptibility to cytomegalovirus, and autoimmunity 
Images in allergy and immunology: Regulatory T cells in allergic disease  Susan C. Foley, MD, David Préfontaine, MSc, Michelle D'Antoni, BSc, Qutayba Hamid,
Autophagy: Nobel Prize 2016 and allergy and asthma research
Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells  Sun Ying, MD, PhD,
New pathways for itching in patients with atopic dermatitis?
Sara Paveglio, PhD, MS, Erin Bennett, MS, Kelly L. Hawley, PhD, Adam P
Cagri Yildirim-Toruner, MD, Betty Diamond, MD 
Analysis of the lineage relationship between mast cells and basophils using the c-kit D816V mutation as a biologic signature  Can N. Kocabas, MD, Akif.
The Editors' Choice Journal of Allergy and Clinical Immunology
Baochen Shi, PhD, Nathanael J
Reply Journal of Allergy and Clinical Immunology
Innate immune defects in atopic dermatitis
Anaphylaxis Journal of Allergy and Clinical Immunology
Erika von Mutius, MD, MSc  Journal of Allergy and Clinical Immunology 
Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis  Eva Gros, MSc, Caroline Bussmann,
Endotoxin and the lung: Insight into the host-environment interaction
Cytokine modulation of atopic dermatitis filaggrin skin expression
Expression of prostaglandin E2 receptor subtypes on cells in sputum from patients with asthma and controls: Effect of allergen inhalational challenge 
Environmental factors and eosinophilic esophagitis
Kinase inhibitors in clinical practice: An expanding world
Lisa A. Beck, MD, Sarbjit Saini, MD 
Contrasting pathogenesis of atopic dermatitis and psoriasis—Part II: Immune cell subsets and therapeutic concepts  Emma Guttman-Yassky, MD, PhD, Kristine.
Natural history of cow’s milk allergy
Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2010  Scott H. Sicherer, MD, Donald Y.M.
Itching as a systemic disease
Presentation transcript:

The cutaneous innate immune response in patients with atopic dermatitis  I-Hsin Kuo, MS, Takeshi Yoshida, PhD, Anna De Benedetto, MD, Lisa A. Beck, MD  Journal of Allergy and Clinical Immunology  Volume 131, Issue 2, Pages 266-278 (February 2013) DOI: 10.1016/j.jaci.2012.12.1563 Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 The skin as an impenetrable shield. The SC is the first physical barrier protecting the skin from the environment. Once this barrier has been breached, TJs found at the level of the stratum granulosum (SG) provide an additional barrier. Disruption of both physical barriers is thought to enable the uptake of allergens, irritants, and microbes by Langerhans cells (LC)/DCs. Keratinocytes produce AMPs as a chemical barrier in response to pathogen colonization/infection and tissue wounding to maintain skin homeostasis. The skin surface is colonized with a diverse array of microorganisms (microbiome barrier), which is thought to regulate local immune responses and to inhibit pathologic microbes. The itch-scratch cycle and cutaneous microbes first promote immune responses from keratinocytes and, only if needed, from a number of hematopoietic cells, including T cells, neutrophils (Neut cells), eosinophils (Eos), LCs/DCs, NK cells, and mast cells. Collectively, these cells constitute the cutaneous immunologic barrier. PRRs regulate the function of all of these barriers (physical, chemical, microbiome, and immunologic). SB, Stratum basale; SG, stratum granulosum; SS, stratum spinosum. The figure is modified from Swindle EJ, Collins JE, Davies DE. Breakdown in epithelia barrier function in patients with asthma: identification of novel therapeutic approaches. J Allergy Clin Immunol 2009;124:23-36. Journal of Allergy and Clinical Immunology 2013 131, 266-278DOI: (10.1016/j.jaci.2012.12.1563) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 TLR2 and TLR3 are expressed below the TJs. Photomicrographs demonstrating the spatial relationship between TJs denoted by the presence of immunoreactivity for occludin (red) and 2 innate immune receptors highly relevant for AD (ie, TLR2 [left panel, green] and TLR3 [right panel, green]) are shown. Nuclei (4′-6-diamidino-2-penylindole dihydrochloride) are denoted by blue staining in these whole mounts of adult human epidermis (bars = 40 μm). In the bottom panel Z-stack images through the stratum granulosum (SG) to the stratum basale (SB) are rotated 90° (thickness = 15 μm). The image to the right summarizes the staining patterns and their intensity. Cell membrane expression of TLR2 is only observed below the TJs at the level of the stratum spinosum (SS) and SB. Faint cytosolic TLR2 immunoreactivity is observed in SG keratinocytes. The biologic significance of this intracellular staining is unclear. Similarly, the intracellular innate immune receptor TLR3 is found only in the cytoplasm of keratinocytes below the TJs (at the level of the SS and SB). Journal of Allergy and Clinical Immunology 2013 131, 266-278DOI: (10.1016/j.jaci.2012.12.1563) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions